{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:10:18Z","timestamp":1740046218933,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1124\/mol.106.023721","type":"journal-article","created":{"date-parts":[[2006,2,24]],"date-time":"2006-02-24T01:48:59Z","timestamp":1140745739000},"page":"1510-1512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["New Assignments for Multitasking Signal Transduction Inhibitors"],"prefix":"10.1016","volume":"69","author":[{"given":"Zhihong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn E.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.106.023721_bib1","first-page":"L826","article-title":"Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus","volume":"284","author":"Balasubramaniam","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.106.023721_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/35074588","article-title":"PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor","volume":"3","author":"Bergsten","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1124\/mol.106.023721_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Blume-Jensen","year":"2001","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.106.023721_bib4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1749-6632.1995.tb26691.x","article-title":"Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation","volume":"66","author":"Bornfeldt","year":"1995","journal-title":"Ann NY Acad Sci USA"},{"key":"10.1124\/mol.106.023721_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","article-title":"Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors","volume":"295","author":"Buchdunger","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.106.023721_bib6","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1124\/mol.105.020172","article-title":"Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib)","volume":"69","author":"Chen","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.023721_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/mol.106.023721_bib8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/35057046","article-title":"Cancer and genomics","volume":"409","author":"Futreal","year":"2001","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.106.023721_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.295.4.369","article-title":"Looking beyond imatinib: next line of targeted drugs for CML shows promise","volume":"295","author":"Hampton","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1124\/mol.106.023721_bib10","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2002.20.6.1692","article-title":"Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies","volume":"20","author":"Heinrich","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1124\/mol.106.023721_bib11","first-page":"79","article-title":"Signal transduction via platelet-derived growth factor receptors","volume":"1378","author":"Heldin","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.106.023721_bib12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1124\/mol.106.023721_bib13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1183\/09031936.98.11030554","article-title":"Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients","volume":"11","author":"Humbert","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1124\/mol.106.023721_bib14","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/mol.106.023721_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1098\/rstb.1998.0228","article-title":"The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease","volume":"353","author":"Hunter","year":"1998","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1124\/mol.106.023721_bib16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/01.RES.75.4.682","article-title":"Different functions of the platelet-derived growth factor-alpha and -beta receptors for the migration and proliferation of cultured baboon smooth muscle cells","volume":"75","author":"Koyama","year":"1994","journal-title":"Circ Res"},{"key":"10.1124\/mol.106.023721_bib17","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1101\/gad.8.16.1875","article-title":"Mice deficient for PDGF B show renal, cardiovascular and hematological abnormalities","volume":"8","author":"Leveen","year":"1994","journal-title":"Genes Dev"},{"key":"10.1124\/mol.106.023721_bib18","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1126\/science.7892601","article-title":"Tyrosine kinase inhibition: an approach to drug development","volume":"267","author":"Levitzki","year":"1995","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.106.023721_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/35010579","article-title":"PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor","volume":"2","author":"Li","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1124\/mol.106.023721_bib20","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1242\/dev.125.17.3313","article-title":"Paracrine PDGF-B\/PDGF-Rb signaling controls mesangial cell development in kidney glomeruli","volume":"125","author":"Lindahl","year":"1998","journal-title":"Development"},{"key":"10.1124\/mol.106.023721_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.277.5323.242","article-title":"Pericyte loss and microaneurysm formation in PDGF-B-deficient mice","volume":"277","author":"Lindahl","year":"1997","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.106.023721_bib22","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/mol.106.023721_bib23","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.106.023721_bib24","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.jcrs.2005.10.029","article-title":"Imatinib as a cause of cystoid macular edema following uneventful phacoemulsification surgery","volume":"12","author":"Masood","year":"2005","journal-title":"J Cataract Refract Surg"},{"key":"10.1124\/mol.106.023721_bib25","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1158\/0008-5472.CAN-05-0259","article-title":"In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants","volume":"65","author":"O'Hare","year":"2005","journal-title":"Cancer Res"},{"key":"10.1124\/mol.106.023721_bib26","series-title":"Peptide Growth Factors and Their Receptors I","first-page":"173","article-title":"Platelet-derived growth factor","author":"Raines","year":"1990"},{"key":"10.1124\/mol.106.023721_bib27","first-page":"3649","article-title":"Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases","volume":"35","author":"Robbins","year":"1994","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1124\/mol.106.023721_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/08977199909002130","article-title":"Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes","volume":"16","author":"Rosenkranz","year":"1999","journal-title":"Growth Factors"},{"key":"10.1124\/mol.106.023721_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0959-437X(01)00273-8","article-title":"Rational therapeutic intervention in cancer: kinases as drug targets","volume":"21","author":"Sawyers","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"10.1124\/mol.106.023721_bib30","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","article-title":"Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase","volume":"289","author":"Schindler","year":"2000","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.106.023721_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1099480","article-title":"Overriding imatinib resistance with a novel ABL kinase inhibitor","volume":"305","author":"Shah","year":"2004","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.106.023721_bib32","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The sequence of the human genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.106.023721_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.critrevonc.2005.06.007","article-title":"Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML)","volume":"57","author":"Walz","year":"2006","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24068159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24068159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.106.023721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:06:50Z","timestamp":1740042410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24068159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0026895X24068159"],"URL":"https:\/\/doi.org\/10.1124\/mol.106.023721","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Assignments for Multitasking Signal Transduction Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.106.023721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}